Brainstorm Cell Therapeutics Inc. Gains 22.67%

Tue 18 Feb 20 at 05:30 PM
Brainstorm Cell Therapeutics Inc. Gains 22.67%

Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ) jumped higher at $6.33, representing a gain of 22.7%. On Mon 17 Feb 20, BCLI:NASDAQ touched a New 2-Week Intraday High of $5.79. The stock appeared on our News Catalysts scanner on Tue 18 Feb 20 at 07:43 AM in the 'EARNINGS' category. From Mon 27 Jan 20, the stock recorded 42.86% Up Days and 33.33% Green Days

About Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ)

Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.